• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Hypertension (update)

Hypertension: management of hypertension in adults in primary care

Status:	History
Publication date:	August 2011
Wave:	2
Process:	CG
Topic area: Cardiovascular

Project team | Schedule | Project history | Key documents

 

NICE project team

Centre for clinical practice lead:	Philip Alderson
Communications manager:	Philip Ranson
Guidelines commissioning manager:	Sarah Dunsdon
Guidelines coordinator:	Andrew Gyton
Patient involvement lead:	Barbara Meredith
Implementation lead:	Katie Worrall
Lead collaborating centre:	National clinical guidelines centre ? acute and chronic conditions
Guidelines Development Group:	The Guideline Development Group (GDG) oversees the development process.

Top

Email enquiries

If you have any queries please email nice@nice.org.uk

Top

 

Provisional schedule

Scoping workshop:	17 February 2010
Consultation on draft scope with stakeholders:	11 March - 12 April 2010
Consultation on draft guideline with stakeholders:	22 February - 22 March 2011
Pre-publication check:	07 June 2011 - 21 June 2011
Publication date:	August 2011

Top

 

Project history

Date Update 7 June 2011 The final draft of the full guideline is available for its pre-publication check. If you wish to report a factual error you need to do so via one of the registered stakeholder organisations listed, by the deadline shown. 10 June 2010 The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process. The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG.   Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline.  Please see timescales above for dates of consultation with stakeholders. 26 June 2009 The National Institute for Health and Clinical Excellence (NICE) has commissioned the National Clinical Guidelines Centre – Acute and Chronic Conditions  to update the clinical guideline on Hypertension, which was published by NICE in June 2006. For further information regarding developing partial update guidelines please see the guidelines development manual 2009.

Top

 

Key documents

Hypertension (update): pre-publication check 07 June 2011 Hypertension (update): guideline development and consultation 14 June 2010 Hypertension (update): scoping workshop, consultation and final scope 14 June 2010 Hypertension (update): stakeholder lists and how to register 09 February 2010 The Guideline Development Process - An overview for Stakeholders, the Public and the NHS 26 May 2009

This page was last updated: 24 August 2011